viral
pathogen
evolv
wide
rang
tactic
evad
host
immun
respons
thu
propag
effect
one
effici
tactic
divert
host
immun
respons
toward
immunodomin
decoy
epitop
induc
nonneutr
antibodi
toward
epitop
therefor
expect
amount
decoy
epitop
subunit
vaccin
affect
level
neutral
antibodi
immun
anim
studi
test
hypothesi
gener
antibodi
specif
decoy
epitop
capsid
protein
porcin
circoviru
type
use
antibodi
found
two
commerci
vaccin
contain
statist
differ
amount
decoy
epitop
vaccin
lower
level
decoy
epitop
induc
significantli
higher
level
neutral
antibodi
immun
antibodi
use
analyt
tool
monitor
qualiti
vaccin
batch
batch
viral
pathogen
evolv
wide
rang
tactic
evad
host
immun
respons
propag
effect
one
tactic
divert
host
immun
respons
decoy
decoy
epitop
report
wide
varieti
virus
includ
human
immunodefici
viru
hiv
felin
immunodefici
viru
fiv
hepat
c
foot
mouth
diseas
middleeast
respiratori
syndrom
coronaviru
sever
fever
thrombocytopenia
syndrom
viru
porcin
reproduct
respiratori
syndrom
viru
prrsv
murin
porcin
circoviru
type
recombin
mutant
capsid
protein
cp
delet
decoy
epitop
induc
higher
level
virusneutr
antibodi
wild
type
protein
expect
higher
level
decoy
epitop
prepar
batch
subunit
vaccin
would
decreas
efficaci
howev
possibl
test
hypothesi
measur
level
decoy
epitop
vaccin
antibodi
specif
decoy
epitop
readili
avail
spheric
structur
icosahedr
symmetri
structur
protein
viru
cp
includ
major
antigen
determin
use
subunit
vaccin
previou
studi
show
epitop
compos
amino
acid
residu
cp
immunodomin
among
antigen
determin
epitop
buri
insid
viruslik
particl
vlp
structur
fig
antibodi
epitop
react
intact
viru
therefor
nonneutr
expect
pcv
infect
elicit
humor
respons
cp
epitop
drove
product
nonneutr
antibodi
therefor
previou
infect
pcv
decreas
vaccin
prevent
futur
infect
sinc
first
vaccin
introduc
global
market
nine
subunit
vaccin
becom
avail
howev
expect
contain
differ
amount
incomplet
vlp
nonuniformli
aggreg
cp
expos
cp
epitop
incomplet
vlp
induc
product
nonneutr
antibodi
reduc
vaccin
efficaci
analyt
tool
measur
amount
cp
epitop
prepar
batch
vaccin
possibl
correl
epitop
level
neutral
activ
vaccin
studi
develop
antibodi
specif
cp
epitop
determin
rel
amount
cp
epitop
two
commerci
avail
vaccin
analyz
influenc
epitop
level
induct
neutral
antibodi
prepar
vlp
recombin
protein
peptid
conjug
cp
amino
acid
aa
express
baculovirusinfect
insect
cell
previous
describ
gene
genbank
clone
pfastbac
express
vector
invitrogen
carlsbad
ca
usa
transfect
cell
cultur
supernat
contain
recombin
baculoviru
harvest
use
infect
separ
batch
cell
day
vlp
purifi
cultur
supernat
sucros
gradient
ultracentrifug
recombin
cp
delet
ntermin
region
protein
deln
cp
aa
express
escherichia
coli
purifi
describ
previous
synthet
cp
peptid
stidyfqpnnkrc
chemic
synthes
use
fmoc
solidphas
peptid
synthesi
peptron
inc
daejeon
south
korea
conjug
bovin
serum
albumin
bsa
keyhol
limpet
hemocyanin
klh
white
leghorn
chicken
immun
klhconjug
cp
peptid
phagedisplay
chicken
singlechain
variabl
fragment
scfv
librari
construct
use
total
rna
isol
bone
marrow
spleen
bursa
fabriciu
immun
chicken
previous
describ
posit
clone
enrich
biopan
screen
phage
enzym
immunoassay
describ
previous
gene
encod
select
scfv
clone
subclon
modifi
mammalian
express
vector
encod
c
k
domain
human
igg
region
scfvc
k
fusion
protein
anticp
antibodi
purifi
cultur
supernat
transient
transfect
cell
use
kappaselect
resin
ge
fig
novel
antibodi
specif
cp
epitop
threedimension
structur
pdb
visual
pymol
one
capsid
protein
cp
immunodomin
cp
decoy
epitop
mark
green
red
respect
b
enzym
immunoassay
use
anticp
antibodi
amount
antibodi
bound
antigen
coat
microtit
plate
detect
hrpconjug
goat
antihuman
c
k
antibodi
result
mean
standard
deviat
experi
conduct
triplic
p
p
twotail
unpair
student
ttest
c
immunoblot
analysi
use
anticp
antibodi
gel
electrophoresi
antigen
transfect
nitrocellulos
membran
membran
probe
anticp
antibodi
healthcar
london
uk
accord
manufactur
instruct
well
microtit
plate
corn
coat
bsaconjug
cp
peptid
deln
cp
purifi
vlp
coat
buffer
nahco
ph
block
wv
bsa
phosphatebuff
salin
pb
incub
mgml
anticp
antibodi
horseradish
peroxidas
hrp
conjug
goat
antihuman
c
k
antibodi
chemiconmillipor
billerica
usa
ad
well
wash
vv
tween
pb
pbst
tetramethyl
benzidin
tmb
gendepot
barker
tx
usa
substrat
solut
ad
absorb
measur
nm
multiskan
ascent
micropl
reader
labsystem
helsinki
finland
dissolv
protein
bsaconjug
cp
peptid
boil
min
lithium
dodecyl
sulfat
sampl
buffer
reduc
agent
invitrogen
sampl
electrophoret
separ
nupag
bistri
gel
invitrogen
transfer
nitrocellulos
membran
block
wv
skim
milk
trisbuff
salin
membran
incub
mgml
anticp
antibodi
probe
hrpconjug
goat
antihuman
c
k
antibodi
chemiconmillipor
blot
visual
use
supersign
west
pico
chemiluminesc
substrat
thermo
fisher
scientif
il
usa
anim
experi
perform
approv
institut
anim
care
use
committe
biopoa
permit
collect
sera
pig
pig
infect
histori
competit
enzym
immunoassay
perform
describ
previous
follow
appropri
modif
preincub
noninfect
infect
porcin
sera
n
serial
dilut
anticp
antibodi
mixtur
ad
microtit
plate
coat
bsaconjug
cp
peptid
irrelev
scfv
fuse
c
k
domain
use
isotypematch
control
amount
bound
porcin
igg
determin
hrpconjug
goat
antiporcin
igg
antibodi
santa
cruz
biotechnolog
tx
usa
tmb
use
substrat
hrp
randomli
design
two
nine
commerci
vaccin
level
total
antigen
prepar
vlp
deln
cp
two
commerci
vaccin
measur
enzym
immunoassay
use
polyclon
antibodi
veterinari
diagnost
laboratori
iowa
state
univers
iowa
usa
hrpconjug
goat
antirabbit
igg
antibodi
bethyl
laboratori
montgomeri
tx
usa
describ
previous
monitor
cp
epitop
level
perform
enzym
immunoassay
use
anticp
antibodi
hrpconjug
goat
antihuman
c
k
antibodi
chemiconmillipor
previous
describ
twenti
guinea
pig
randomli
divid
four
group
n
guinea
pig
immun
intraderm
ml
vlp
deln
cp
commerci
vaccin
four
week
immun
whole
blood
collect
sera
prepar
indirect
fluoresc
assay
ifa
perform
use
sera
cell
previous
describ
monitor
reactiv
sera
cp
epitop
enzym
immunoassay
use
bsaconjug
cp
peptid
hrpconjug
antiguinea
pig
igg
antibodi
bethyl
laboratori
perform
describ
previous
perform
serum
viru
neutral
assay
use
cell
describ
previous
statist
analysi
conduct
use
graphpad
prism
graphpad
softwar
inc
san
diego
ca
usa
result
express
mean
standard
deviat
indic
number
independ
measur
statist
signific
determin
use
twotail
unpair
student
test
nonparametr
mannwhitney
u
test
twoway
analysi
varianc
anova
use
analyz
relationship
two
independ
factor
statist
analys
p
valu
consid
statist
signific
phage
display
librari
combinatori
scfv
prepar
use
chicken
immun
klhconjug
cp
peptid
complex
librari
exceed
enrich
scfv
clone
specif
reactiv
cp
epitop
six
total
round
biopan
perform
round
biopan
monomer
deln
cp
cp
peptid
altern
use
antigen
n
terminu
cp
play
key
role
assembl
vlp
structur
thu
delet
ntermin
region
expos
cp
epitop
del
cp
biopan
reactiv
individu
clone
cp
peptid
deln
cp
vlp
test
phage
enzym
immunoassay
clone
select
recombin
scfvc
k
fusion
protein
prepar
use
mammalian
express
system
recombin
scfvc
k
fusion
protein
react
cp
peptid
deln
cp
vlp
fig
immunoblot
analysi
recombin
scfvc
k
fusion
protein
reactiv
cp
peptid
deln
cp
also
vlp
cp
epitop
vlp
expos
denatur
occur
sampl
prepar
fig
although
cp
segment
short
harbor
one
antigen
determin
confirm
number
antigen
determin
use
polyclon
sera
pig
infect
competit
enzym
immunoassay
employ
microtit
plate
coat
bsaconjug
cp
peptid
hrpconjug
antiporcin
igg
antibodi
recombin
anticp
antibodi
almost
complet
inhibit
bind
natur
occur
anticp
antibodi
peptid
pig
sera
fig
result
conclud
one
antigen
determin
cp
residu
rel
amount
antigen
two
commerci
avail
vaccin
determin
enzym
immunoassay
use
purifi
vlp
recombin
deln
cp
protein
amount
coat
antigen
determin
polyclon
antibodi
quantiti
bound
antibodi
statist
differ
vaccin
conclud
contain
similar
amount
recombin
cp
fig
determin
rel
amount
cp
epitop
two
vaccin
enzym
immunoassay
employ
anticp
antibodi
fig
found
higher
amount
anticp
antibodi
bound
vaccin
acoat
well
vaccin
bcoat
well
conclud
vaccin
contain
higher
amount
cp
epitop
monitor
humor
respons
collect
sera
guinea
pig
n
immun
vaccin
control
sera
also
immun
vlp
recombin
deln
cp
parallel
confirm
success
vaccin
perform
ifa
describ
previous
use
cell
statist
differ
antibodi
titer
sera
obtain
anim
immun
two
vaccin
expect
sera
anim
immun
deln
cp
show
statist
lower
antibodi
titer
compar
group
p
fig
enzym
immunoassay
employ
microtit
plate
coat
bsaconjug
cp
peptid
sera
anim
immun
vaccin
significantli
higher
antibodi
titer
vaccin
bvaccin
anim
p
fig
addit
sera
deln
cpimmun
anim
significantli
higher
antibodi
titer
vlpimmun
anim
p
measur
compar
neutral
activ
sera
vitro
infect
experi
employ
viru
cell
sera
vaccin
bimmun
anim
significantli
higher
neutral
antibodi
titer
sera
vaccin
aimmun
anim
p
fig
also
sera
vlpimmun
anim
show
significantli
higher
neutral
activ
sera
vlpimmun
anim
p
sinc
emerg
consider
effort
produc
effect
vaccin
time
main
hurdl
effici
overexpress
cp
later
found
immunodomin
cp
epitop
buri
viral
capsid
assembl
antibodi
target
epitop
nonneutr
common
viral
immuneevas
mechan
infect
inevit
provok
exposur
decoy
epitop
therefor
less
effect
gener
protect
humor
respons
immun
subunit
vaccin
minim
amount
expos
decoy
epitop
research
predict
incomplet
vlp
expos
immunodomin
cp
epitop
contamin
prepar
subunit
vaccin
drive
humor
respons
produc
nonneutr
antibodi
could
quantifi
expos
immunodomin
cp
epitop
subunit
vaccin
lack
proper
analyt
tool
rectifi
gener
monoclon
antibodi
specif
immunodomin
cp
epitop
antibodi
librari
gener
use
chicken
immun
cp
peptid
recombin
anticp
antibodi
preferenti
react
deln
cp
expos
cp
epitop
compar
vlp
enzym
immunoassay
fig
length
linear
bcell
epitop
vari
wide
amino
acid
confirm
cp
peptid
behav
singl
epitop
competit
enzym
immunoassay
recombin
cp
antibodi
almost
complet
inhibit
bind
pig
sera
cp
peptid
use
antibodi
quantifi
rel
amount
cp
epitop
two
commerci
avail
vaccin
found
vaccin
contain
significantli
decoy
epitop
vaccin
b
immun
vaccin
induc
significantli
higher
antibodi
respons
decoy
epitop
vaccin
b
support
find
vaccin
b
induc
higher
amount
neutral
antibodi
summari
research
demonstr
amount
immunodomin
decoy
epitop
present
vaccin
measur
epitopespecif
antibodi
measur
level
decoy
epitop
could
predict
efficaci
vaccin
induct
neutral
antibodi
titer
believ
anticp
antibodi
use
monitor
vari
qualiti
subunit
vaccin
batch
batch
fig
recombin
anticp
antibodi
inhibit
bind
natur
occur
antibodi
preincub
sera
noninfect
infect
pig
b
anticp
antibodi
n
mixtur
ad
cp
peptideco
microtit
plate
amount
bound
porcin
antibodi
measur
hrpconjug
antiporcin
igg
antibodi
absorb
measur
nm
result
mean
standard
deviat
experi
conduct
triplic
use
sera
three
pig
group
author
declar
conflict
interest
